Zhong Z, Yu H, Tong Y, Li J
Int J Gen Med. 2025; 18:1111-1125.
PMID: 40026809
PMC: 11872099.
DOI: 10.2147/IJGM.S512814.
Chen Y, Zhang J, Zheng W, Xu H
PLoS One. 2025; 20(2):e0315927.
PMID: 39913607
PMC: 11801720.
DOI: 10.1371/journal.pone.0315927.
Liao J, Duan Y, Xu X, Liu Y, Zhan C, Xiao G
Discov Oncol. 2025; 16(1):119.
PMID: 39909964
PMC: 11799505.
DOI: 10.1007/s12672-025-01863-2.
Turpo-Peqquena A, Luna-Prado S, Valencia-Arce R, Del-Carpio-Carrazco F, Gomez B
Curr Issues Mol Biol. 2025; 47(1).
PMID: 39852155
PMC: 11763394.
DOI: 10.3390/cimb47010040.
Kim Y, Patil K, Pai S
BMC Res Notes. 2025; 18(1):23.
PMID: 39833890
PMC: 11744947.
DOI: 10.1186/s13104-025-07092-8.
MiRNAs as major players in brain health and disease: current knowledge and future perspectives.
Kapplingattu S, Bhattacharya S, Adlakha Y
Cell Death Discov. 2025; 11(1):7.
PMID: 39805813
PMC: 11729916.
DOI: 10.1038/s41420-024-02283-x.
Doublecortin regulates the mitochondrial-dependent apoptosis in glioma via Rho-A/Net-1/p38-MAPK signaling.
Nadeem I, Han Z, Xiaoliang H, Adzraku S, Kambey P, Kanwore K
Mol Med. 2024; 30(1):272.
PMID: 39719558
PMC: 11668075.
DOI: 10.1186/s10020-024-01021-4.
A novel risk model consisting of nine platelet-related gene signatures for predicting prognosis, immune features and drug sensitivity in glioma.
Wei S, Zhou J, Dong B
Hereditas. 2024; 161(1):52.
PMID: 39707577
PMC: 11662788.
DOI: 10.1186/s41065-024-00355-7.
Construction and validation of a novel prognostic model with palmitoylation-related genes for glioblastoma.
Qin G, Pang G, Wu S, Bi S, Lan S, Tang X
Transl Cancer Res. 2024; 13(11):6117-6135.
PMID: 39697698
PMC: 11651772.
DOI: 10.21037/tcr-24-787.
Bufotalin Induces Oxidative Stress-Mediated Apoptosis by Blocking the ITGB4/FAK/ERK Pathway in Glioblastoma.
Tan J, Lin G, Zhang R, Wen Y, Luo C, Wang R
Antioxidants (Basel). 2024; 13(10).
PMID: 39456433
PMC: 11505062.
DOI: 10.3390/antiox13101179.
CSF3R as a potential prognostic biomarker and immunotherapy target in glioma.
Huang M, Zhang L, Wu Y, Zhou X, Wang Y, Zhang J
Cent Eur J Immunol. 2024; 49(2):155-168.
PMID: 39381559
PMC: 11457564.
DOI: 10.5114/ceji.2024.140651.
Construction and validation of a machine learning-based immune-related prognostic model for glioma.
Mao Q, Qiao Z, Wang Q, Zhao W, Ju H
J Cancer Res Clin Oncol. 2024; 150(10):439.
PMID: 39352539
PMC: 11445300.
DOI: 10.1007/s00432-024-05970-5.
Unveiling the role of PSMA5 in glioma progression and prognosis.
Liu W, Jia B, Wang Z, Li C, Li N, Tang J
Discov Oncol. 2024; 15(1):414.
PMID: 39240463
PMC: 11379840.
DOI: 10.1007/s12672-024-01296-3.
Therapeutic potential of arginine deprivation therapy for gliomas: a systematic review of the existing literature.
Yuxiao C, Jiachen W, Yanjie L, Shenglan L, Yuji W, Wenbin L
Front Pharmacol. 2024; 15:1446725.
PMID: 39239650
PMC: 11375294.
DOI: 10.3389/fphar.2024.1446725.
Molecular Determinants for Photodynamic Therapy Resistance and Improved Photosensitizer Delivery in Glioma.
Aebisher D, Woznicki P, Czarnecka-Czapczynska M, Dynarowicz K, Szliszka E, Kawczyk-Krupka A
Int J Mol Sci. 2024; 25(16).
PMID: 39201395
PMC: 11354549.
DOI: 10.3390/ijms25168708.
GLUT5-overexpression-related tumorigenic implications.
Hadzi-Petrushev N, Stojchevski R, Jakimovska A, Stamenkovska M, Josifovska S, Stamatoski A
Mol Med. 2024; 30(1):114.
PMID: 39107723
PMC: 11304774.
DOI: 10.1186/s10020-024-00879-8.
Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges.
Seyhan A
Int J Mol Sci. 2024; 25(14).
PMID: 39063215
PMC: 11277426.
DOI: 10.3390/ijms25147974.
CNN-based glioma detection in MRI: A deep learning approach.
Wang J, Yin L
Technol Health Care. 2024; 32(6):4965-4982.
PMID: 39031408
PMC: 11612952.
DOI: 10.3233/THC-240158.
Leveraging FAM features to predict the prognosis of LGG patients and immunotherapy outcome.
Lin L, Yu H, Xie X, Lei Q, Chen X, Su X
Am J Cancer Res. 2024; 14(6):2731-2754.
PMID: 39005680
PMC: 11236777.
DOI: 10.62347/GIGO3446.
Unveiling the therapeutic prospects of IFNW1 and IFNA21: insights into glioma pathogenesis and clinical significance.
Cheng H, Zhao Y, Hou X, Ling F, Wang J, Wang Y
Neurogenetics. 2024; 25(4):337-350.
PMID: 38958838
DOI: 10.1007/s10048-024-00769-5.